Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (41-50 of 342) with videos related to

Pageof 35
Sort By:
Investigative Ophthalmology & Visual Science|March 26, 2005
Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivityDario Sisto, Maria Trojano, Michele Vetrugno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 7, 2021
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 yearsTommaso Guerra, Francesca Caputo, Bianca Orlando, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2014
Pregnancy, sex and hormonal factors in multiple sclerosisDavid H Miller, Franz Fazekas, Xavier Montalban, et al.
European Neurology|October 4, 2014
Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlightsMaria Trojano, Elisabeth G Celius, Cecile Donzé, et al.
Journal of Clinical Pharmacology|April 24, 2015
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing studyDamiano Paolicelli, Alessia Manni, Vita Direnzo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 15, 2022
Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature reviewLuca Bollo, Carlo Santoro, Giuseppe Libro, et al.
Clinical Case Reports|October 27, 2021
Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-reportCarlo Santoro, Tommaso Guerra, Eustachio D'Errico, et al.
International Journal of Molecular Sciences|November 23, 2018
Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis PathogenesisNicoletta Nuzziello, Laura Vilardo, Paride Pelucchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Postmarketing evidence of disease-modifying drugs in multiple sclerosisMaria Trojano, Damiano Paolicelli, Aurora Fuiani, et al.
Journal of the Neurological Sciences|April 10, 2014
Emotional and neutral verbal memory impairment in Multiple SclerosisPietro Iaffaldano, Rosa Gemma Viterbo, Benedetta Goretti, et al.
Pageof 35

Showing results (41-50 of 342) with videos related to

Sort By:
Pageof 35
Investigative Ophthalmology & Visual Science|March 26, 2005
Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivityDario Sisto, Maria Trojano, Michele Vetrugno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 7, 2021
Long-term comparative analysis of no evidence of disease activity (NEDA-3) status between multiple sclerosis patients treated with natalizumab and fingolimod for up to 4 yearsTommaso Guerra, Francesca Caputo, Bianca Orlando, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2014
Pregnancy, sex and hormonal factors in multiple sclerosisDavid H Miller, Franz Fazekas, Xavier Montalban, et al.
European Neurology|October 4, 2014
Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlightsMaria Trojano, Elisabeth G Celius, Cecile Donzé, et al.
Journal of Clinical Pharmacology|April 24, 2015
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing studyDamiano Paolicelli, Alessia Manni, Vita Direnzo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 15, 2022
Neuromyelitis optica spectrum disorders associated with systemic sclerosis: a case report and literature reviewLuca Bollo, Carlo Santoro, Giuseppe Libro, et al.
Clinical Case Reports|October 27, 2021
Guillain-Barré syndrome associated with inappropriate secretion of antidiuretic hormone following SARS-CoV-2 infection: A case-reportCarlo Santoro, Tommaso Guerra, Eustachio D'Errico, et al.
International Journal of Molecular Sciences|November 23, 2018
Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis PathogenesisNicoletta Nuzziello, Laura Vilardo, Paride Pelucchi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 4, 2008
Postmarketing evidence of disease-modifying drugs in multiple sclerosisMaria Trojano, Damiano Paolicelli, Aurora Fuiani, et al.
Journal of the Neurological Sciences|April 10, 2014
Emotional and neutral verbal memory impairment in Multiple SclerosisPietro Iaffaldano, Rosa Gemma Viterbo, Benedetta Goretti, et al.
Pageof 35